According to a report by the Wall Street Journal, technology sector figures are promising that artificial intelligence will cure disease. However, chief executive officers within the pharmaceutical industry are not convinced by these claims, highlighting a growing divide between tech industry promises and the perspectives of traditional drugmakers.